Abstract
Background:The rate of occurrence of Alzheimer’s disease is increasing around the world. However, there is still no significant breakthrough in the study of its etiology and pathogenesis.
Objective:To screen Alzheimer's disease pathogenic genes, which may be conducive to the elucidation of the pathogenic mechanisms of Alzheimer's disease And predict the pathogenicity by various computer software.
Method:Clinical and neuroimaging examination, Whole Exome Sequencing, and Sanger sequencing were performed in the proband. Mutation sites were verified in 158 subjects.
Results:We reported a proband carrying a probably novel pathogenic mutation, which clinically manifests as progressive memory loss, visual-spatial disorders, apraxia, psychobehavioral disorders, and temperamental and personality changes. Whole Exome Sequencing detected a novel missense mutation at codon 222 (Q222L), which is a heterozygous A to T point mutation at position 665 (c.665A>T) in exon 5 of the presenilin 1 leading to a glutamine-to-leucine substitution. The mutation was also identified by Sanger sequencing in one family member; nevertheless, it was not detected in the other 7 unaffected family members, 50 sporadic Alzheimer's disease patients and 100 control subjects.
Conclusion:A novel mutation in exon 5 of the presenilin 1 gene (Gln222Leu) in a Chinese family with early-onset Alzheimer’s disease has been reported, besides, it was predicted that the missense mutation was probably a novel pathogenic mutation that was reported for the first time in a Chinese family with early-onset Alzheimer’s disease.
Keywords: Early-onset Alzheimer's disease, familial, mutation, PSEN1 Gln222Leu mutation, dementia, memory loss.
[http://dx.doi.org/10.1016/S0140-6736(15)01124-1] [PMID: 26921134]
[PMID: 26337232]
[PMID: 22728850]
[PMID: 26756738]
[http://dx.doi.org/10.1016/j.clineuro.2018.12.016] [PMID: 30599314]
[http://dx.doi.org/10.1016/j.neurobiolaging.2015.09.003]
[PMID: 28350801]
[http://dx.doi.org/10.1038/nmeth.2890] [PMID: 24681721]
[http://dx.doi.org/10.1093/nar/gks539]
[http://dx.doi.org/10.1038/nprot.2009.86] [PMID: 19561590]
[http://dx.doi.org/10.1038/nmeth0410-248] [PMID: 20354512]
[http://dx.doi.org/10.1093/bioinformatics/btv195] [PMID: 25851949]
[PMID: 11524469]
[PMID: 27930341]
[PMID: 27777022]
[PMID: 23380992]
[PMID: 12885573]
[PMID: 22505025]
[PMID: 26481686]
[http://dx.doi.org/10.1523/JNEUROSCI.0954-13.2013] [PMID: 23843529]
[PMID: 8938131]
[PMID: 10327206]